Immunogenicity and safety of a booster dose of an MF59-adjuvanted H5N1 vaccine containing 7.5 _g A/turkey/Turkey/1/2005-like (clade 2.2) H5N1 hemagglutinin, given approximately 18 months after primary vaccination with a heterologous strain, were evaluated. The booster vaccine was well tolerated and induced a robust, cross-reactive immune response.
Fragapane, E., Gasparini, R., Schioppa, F., LAGHI PASINI, F., Montomoli, E., Banzhoff, A. (2010). A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. CLINICAL AND VACCINE IMMUNOLOGY, 17(11), 1817-1819 [10.1128/CVI.00461-09].
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly.
LAGHI PASINI, FRANCO;MONTOMOLI, EMANUELE;
2010-01-01
Abstract
Immunogenicity and safety of a booster dose of an MF59-adjuvanted H5N1 vaccine containing 7.5 _g A/turkey/Turkey/1/2005-like (clade 2.2) H5N1 hemagglutinin, given approximately 18 months after primary vaccination with a heterologous strain, were evaluated. The booster vaccine was well tolerated and induced a robust, cross-reactive immune response.
| File | Dimensione | Formato | |
|---|---|---|---|
|
025-2010_CVI-Fragapane.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
138.52 kB
Formato
Adobe PDF
|
138.52 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/2468
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo